Trial Profile
A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Calcipotriol (Primary) ; Ciclosporin (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Polichem
- 08 Mar 2016 Primary endpoint has been met. (Nail Psoriasis Severity Index score)
- 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology
- 01 Jun 2013 Planned End Date changed from 27 Oct 2011 to 1 Mar 2013 as reported by European Clinical Trials Database.